Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.08 AUD -2.44% Market Closed
Market Cap: 82.9m AUD
Have any thoughts about
Percheron Therapeutics Ltd?
Write Note

Relative Value

The Relative Value of one PER stock under the Base Case scenario is 0.07 AUD. Compared to the current market price of 0.08 AUD, Percheron Therapeutics Ltd is Overvalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PER Relative Value
Base Case
0.07 AUD
Overvaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
4
Median 3Y
385.3
Median 5Y
1 566.8
Industry
2.6
Forward
56.6
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-13.7
Industry
23
Forward
-3
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-15.8
Industry
17.8
vs History
vs Industry
Median 3Y
-10.3
Median 5Y
-15.5
Industry
25.4
vs History
47
vs Industry
18
Median 3Y
5.8
Median 5Y
8.8
Industry
2.2
vs History
87
vs Industry
4
Median 3Y
303.3
Median 5Y
1 523
Industry
2.8
Forward
48.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.4
vs History
vs Industry
Median 3Y
-7.6
Median 5Y
-11.4
Industry
13.7
Forward
-3.1
vs History
vs Industry
Median 3Y
-7.6
Median 5Y
-11.4
Industry
17.2
Forward
-3.1
vs History
vs Industry
Median 3Y
-8.5
Median 5Y
-13.4
Industry
16.5
vs History
vs Industry
Median 3Y
-8.4
Median 5Y
-13.4
Industry
19.3
vs History
vs Industry
4
Median 3Y
30.6
Median 5Y
109.9
Industry
2

Multiples Across Competitors

PER Competitors Multiples
Percheron Therapeutics Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Percheron Therapeutics Ltd
ASX:PER
82.9m AUD 134.8 -7 -5 -5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
758.2B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
367.6B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.1B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
AU
Percheron Therapeutics Ltd
ASX:PER
Average P/E: 33.4
Negative Multiple: -7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top